Evidence map›Paper›PMID 41594074›Full record

ReviewAntibiotics (Basel, Switzerland)2026

Antibiotic Resistance in

Veronika Zdarska, Gabriele Arcari, Milan Kolar, Patrik Mlynarcik

Abstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Biofilm-Mediated Antimicrobial Resistance in PediatricAntibiotics (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Review
  7. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Detection of theVeterinary world · 2026
    Article
  14. Article
  15. Article
  16. Convergence of multidrug resistance with biofilm formation and hypermucoviscosity inAntimicrobial stewardship & healthcare epidemiology : ASHE · 2026
    Article
  17. Article
  18. Phage and endolysin-based inhibition ofFrontiers in cellular and infection microbiology · 2026
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Veronika ZdarskaDepartment of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515 Olomouc, Czech Republic.ORCID 0009-0009-4586-1369
Gabriele ArcariLaboratory of Medical Microbiology and Virology, University Hospital of Varese, 21100 Varese, Italy.ORCID 0000-0001-9629-4637
Milan KolarDepartment of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515 Olomouc, Czech Republic.ORCID 0000-0003-4621-8868
Patrik MlynarcikDepartment of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515 Olomouc, Czech Republic.ORCID 0000-0003-1496-775X

Funding

Ministry of Education, Youth and Sports of the Czech Republic (MŠMT) LX22NPO5103Palacký University Olomouc IGA_LF_2025_022
6 · The paper itself

Abstract

Drug-resistant

Indexed as

antimicrobial resistancebeta-lactamasesefflux pumpsEnterobacteralesKlebsiellaporinstwo-component systems

Identifiers

PMID41594074
PMCPMC12837551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.